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The  response  of  mast  cells  and  serglycin-dependent  proteases  to  parasitic 
infection  -  Studies  on  mast  cells  during  Toxoplasma  gondii  (murine)  and 
Dictyocaulus viviparus (bovine) infection 
Abstract 
The proteoglycan (PG), serglycin (SG), is expressed in several hematopoietic cells 
and  studies  of  the  SG  knockout  mice  (SG
-/-)  revealed  prominent  effects  on  the 
storage of certain mouse mast cell proteases (mMCPs) such as mMCP-4, -5 and -6. 
In this thesis, the role of SGPG during parasitic infection was addressed. Both SG
+/+ 
and SG
-/- animals infected with Toxoplasma gondii had significantly elevated levels of 
hyaluronan and chondroitin sulfate A PG in the peritoneum. In contrast, whereas 
heparin/heparan sulfate was confined to the peritoneal cells in SG
+/+ animals, it was 
almost undetectable in SG
-/- animals. Surprisingly, both SG
+/+ and SG
-/- animals were 
shown to secrete active MC proteases to almost the same levels in the peritoneal 
cavity,  despite  defective  storage  of  proteases  in  SG
-/-  MCs.  Furthermore,  SG
-/- 
animals  showed  a  delayed  neutrophil  recruitment  and  decreased  levels  of 
proinflammatory  cytokines  such  as  IL-6,  IL-12,  TNF-α  and  MCP-1.  In  vitro 
stimulation of peritoneal derived MCs (PCMCs) with soluble Toxoplasma antigen 
induced significantly lower secretion of IL-6, IL-12 and TNF-α in SG
-/- PCMCs 
than in SG
+/+ PCMCs.  
    In addition, when studying aging SG
-/- animals, the SG-deficiency manifested 
as  enlargements  of  lymphoid  tissues,  particularly  spleens,  Peyer’s  patches  and 
bronchus  associated  lymphoid  tissue,  and  was  not  shown  to  be  associated  with 
infection. Analysis of this phenomenon revealed an expansion of naïve lymphocytes 
through an increase in the CD4
+ and CD45RC
+ leukocyte population. Moreover, 
peritoneal macrophages were markedly increased in number in aging SG
-/- animals.  
    In response to Dictyocaulus viviparus infection in calves, tryptase positive MCs in 
the bovine lung and BALF were shown to correlate with disease progression. The 
activity  and  expression  levels  of  tryptase were increased in the lungs of infected 
calves compared to non-infected control animals. 
  In conclusion, MCs are actively involved in the host response to Toxoplasma 
gondii infection in mice and Dictyocaulus viviparus infection in calves. 
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1  Introduction  
In our daily life, we are constantly exposed to infectious agents and in most 
cases we are able to defeat them. To resist infections, we depend on our 
immune system, which consists of immune cells and soluble factors. Since 
the 1960s, there have been impressive advances in our understanding of the 
functional aspects of the immune system. The discovery and application of 
advanced  techniques  such  as  monoclonal  antibody  production, 
immunohisto/cytochemistry,  recombinant  DNA  methodology  and  x-ray 
crystallography,  in  addition  to  the  generation  of  genetically  modified 
animals  (transgenic  and  knockout  mice)  have  aided  the  current 
understanding of immunology. The immune system is composed of two 
major  subdivisions:  the  non-specific  innate  (natural  or  native)  immune 
response and the specific, adaptive (acquired) immune response. The innate 
immune  response  is  our  first  line  of  defense  against  invaders  while  the 
adaptive immune response acts as a second line of defense. Importantly, the 
adaptive system contributes protection through memory when re-exposure 
to pathogens occurs. A hallmark of the adaptive immune system is that it 
performs its specific actions in defined areas such as the lymph nodes that 
drain infected tissue. All blood cells  originate from a common pluripotent, 
hematopoietic stem cell in the bone marrow that becomes committed to 
differentiate  along  one  of  two  major  hematopoietic  branches  to  develop 
into lymphoid cells including NK, B and T cells or myeloid cells such as 
erythroid, megakaryocytic, granulocytic, and monocytic cells. Leukocytes 
can be distinguished by their expression of cluster of differentiation (CD) 
molecules. In addition, secreted cytokines and chemokines active in cellular 
crosstalk can also be used to define different leukocytic cell types.  
 The  leukocyte  cytokine  family  includes  interleukins  (IL),  interferons 
(IFN), and colony- stimulating factors (CSF)(Abul K. Abbas, 2007) (Tizard, 
2009).    12
1.1.1    Innate immunity  
The first arm of innate immunity includes: 
1)  Physical barriers such as intact skin, epithelial cell layers, as well as the 
physical processes of vomiting and diarrhea in the gastrointestinal tract. 
2)  Chemical barriers, such as antimicrobial substances (saliva, tears, 
nasal secretions, mucus etc.) produced at the epithelial surface. 
3)  Biological  factors such as the commensal flora of the skin and 
gastrointestinal  tract,  which  can  prevent  colonization  by 
pathogenic  bacteria.  The  persistence  and  virulence  of  invading 
microorganisms,  however,  can  enable  them  to  eventually 
overcome  and  breach  some  of  these  physical  obstacles.  Once 
inside the host organism, they will encounter the second arm of 
innate immunity. 
The second arm of innate immunity comprises:  
1) The humoral system, consisting of antibodies (which are also part of 
adaptive  immunity,  see  below)  and  the  complement  system. 
Antibodies  are  targeted  to  recognize  foreign  molecules  (including 
those expressed by invading organisms) and contain activating domains 
for  immune  cells  and  complement  in  their  constant  regions.  The 
complement cascade, which includes over 20 proteins, is designed to 
attack and lyse foreign organisms. In addition, cleaved products such as 
C3b/C4b can opsonize organisms and prepare them for phagocytosis 
by macrophages and granulocytes. 
2) Sentinel  cells,  such  as  MCs,  macrophages  and  dendritic  cells 
(DCs), located in areas close to exterior surfaces. 
3) The  recruitment  of  granulocytic  cell  types  such  as  NK  cells, 
eosinophils, and neutrophils to the site of infection. Their main 
tasks are to eliminate pathogens either by direct contact or by 
phagocytosis, to serve as antigen-presenting cells (APCs) to T 
cells, and to produce a vast number of mediators for activation of 
the adaptive immune cells.  
The MC, armed with multiple types of receptors capable of recognizing an 
intruder and releasing a multitude of essential signals, is believed to work as 
an  alarm  clock  that  wakes  the  immune  system  upon  an  assault.  
Macrophages are the main scavengers in tissues and are able to kill invaders, 
present antigen, control inflammation, repair damaged tissues and cells, and 
assist  in  the  healing  process.  Immature,  circulating  monocytes  are  found 
mostly  in  the  blood  stream.  When  they  extra-vasate  into  tissues,  they 
undergo a maturation process to become tissue macrophages. DCs are the 
only sentinel cells that can activate naïve T cells and thus are essential for 13 
 
initiating immune responses. NK cells, which originate from the lymphoid 
branch of the hematopoietic tree, are dedicated to killing tumor cells and 
virus infected cells via a non-specific mechanism. Eosinophils are mainly 
involved in the battle against helminthic parasites. Neutrophils engage by 
phagocytosis of infectious agents into phagosomes, which subsequently fuse 
with  the  lysosomes  to  form  phagolysosomes,  where  the  pathogen  is 
destroyed  by  digestive  enzymes.  Despite  the  variety  of  the  defensive 
measures  that  comprise  innate  cellular  immunity,  microbes  can  still 
occasionally evade these barriers. The most important function of innate 
immunity, then, may be to stall the speed of infection and thereby give the 
adaptive (acquired) immune system ample time to respond (Tizard, 2009; 
Abul K. Abbas, 2007). 
1.1.2  Adaptive immunity  
Adaptive  or  acquired  immunity  consists  of  B  and  T  lymphocytes  that 
generate highly antigen-specific responses, as well as memory cells against 
the invaders. The memory function enables rapid and specific responses on 
a second exposure to a pathogen. Once activated, B lymphocytes produce 
soluble  antibodies  (as  a  part  of  humoral  immunity)  that  recognize, 
neutralize,  and  eliminate  mainly  extracellular  microbes  and  microbial 
antigens  (toxins).  T  lymphocytes,  which  lie  at  the  core of cell-mediated 
immunity, target mainly intracellular organisms, such as viruses, as well as 
certain bacteria and parasites that survive and proliferate within host cells, 
making these pathogens inaccessible to circulating antibodies. Two distinct 
populations of T lymphocytes, helper T cells and cytotoxic T lymphocytes 
(CTLs), have been described. There are three subpopulations of helper T 
cells; Th1 cells secrete IL-2 and IFN-γ to promote cell-mediated responses 
such as macrophage activation, Th2 cells secrete IL-4 and IL-10 to enhance 
antibody production by B cells and Th17 cells secrete IL-17 and promote 
some inflammatory reactions. CTLs kill infected cells that present foreign 
antigens on their surface, such as cells infected with viruses and intracellular 
microbes.  Regulatory  T  lymphocytes  suppress  immune  responses  and 
maintain  self-tolerance  (unresponsiveness  to  self  antigen).  These  cells 
recently  gained  more  attention  as  potential  clinical  targets  for  the 
suppression of certain types of cancers and autoimmune diseases (Tizard, 
2009; Abul K. Abbas, 2007). 
1.1.3  Host-pathogen interactions    
Animals can be infected by a number of different microorganisms, such as 
viruses,  bacteria,  and  protozoa.  These  microorganisms  have  fundamental 
differences from each other in their physiology, structures, and mechanisms   14
of propagation, all of which contribute to various effects on the immune 
response.  Pattern  recognition  receptors  (PRRs)  on  immune  cells  can 
recognize conserved pathogen-associated molecular patterns (PAMPs). The 
PRRs  are  activation  units  for  the  innate  response  during  an  infection. 
PAMPs can have quite distinct chemical structures, but all have common 
features  recognized  by  PRRs,  which  are  expressed  only  by  microbial 
pathogens, and not by host cells. The best-known examples of PAMPs are 
bacterial  lipopolysaccharides,  peptidoglycans,  lipoteichoic  acids,  mannans, 
bacterial DNA and glucans (Rasmussen et al., 2009; Medzhitov & Janeway, 
1997;  Janeway,  1992).  The  PAMP-activated  PRRs  induce  intracellular 
signaling, gene expression and on the initiation of antimicrobial as well as 
pro- and anti-inflammatory activities. The innate response is a rapid line of 
defense against infection, and also prompts the processes that ultimately lead 
to the expansion of the adaptive immune response and the establishment of 
immunological memory (Rasmussen et al., 2009; Janeway, 1989) (Ishii et 
al., 2008).   
The  expression  of  glycophoshatidylinostitol  (GPIs)  lipids  in  cell 
membranes varies widely among different organisms, species and even cell 
types. GPIs are expressed ubiquitously by eukaryotes as well as pathogenic 
parasitic protozoa such as Trypansoma, Leishmania, and Plasmodium species, 
which express GPIs abundantly, thereby constituting the major PAMPs in 
these  parasites.  The  main  function  of  GPIs  is  to  anchor  functionally 
important proteins to cell surfaces. Plasmodium-derived GPIs, referred to as 
malaria  toxins,  induce  pro-inflammatory  responses  by  the  host  through 
TLR2/MyD88  signaling.  This  recognition  is  essential  not  only  for 
combating parasite growth before the development of adaptive immunity, 
but also for initiating and regulating adaptive immunity for effective parasite 
clearance. Additionally, the proteins anchored via GPIs in P. falciparum are 
involved in the invasion of erythrocytes and are thus essential for parasite 
surviva (Mayor & Riezman, 2004) (Gowda, 2007).  Generally, PRRs are 
expressed  on  many  effector  cells  of  the  innate  immune  system,  most 
importantly on macrophages, dendritic cells, and B lymphocytes, i.e. the 
specialized  antigen  presenting  cells.  PRRs  can  be  further  divided  into 
secreted,  endocytic,  and  signaling  types.  The  secreted  types  function  as 
opsonins,  by  binding  to  microbial  cell  walls  and  flagging  them  for 
recognition  by  the  complement  system  and  phagocytes.  The  best-
characterized example of secreted receptors is the mannan-binding lectin, 
which binds to carbohydrates on gram-positive and gram-negative bacteria 
and yeast as well as parasites and activates the complement cascade (Epstein 
et al., 1996) (Medzhitov & Janeway, 1997). Endocytic PRRs are expressed 15 
 
on  the  surface  of  phagocytes,  mediating  the  uptake  and  delivery  of 
pathogens into lysosomes, which after lysosomal processing are presented as 
pathogen-derived  proteins  by  major  histocompatibility-complex  (MHC) 
molecules  on  the  surface  of  the  APCs  (Fraser  et  al.,  1998).  In  addition, 
signaling receptors recognize PAMPs, activate signal-transduction pathways 
and  induce  the  expression  of  various immune  response  genes,  including 
inflammatory cytokines. The best example of signaling receptors is the Toll-
like  receptor  (TLR)  family,  which  appear  to  play  a  major  role  in  the 
induction of immune and inflammatory responses (Ishii et al., 2008). The 
Toll receptors were first identified in Drosophila spp. as a component of a 
signaling pathway. Orthologues of Drosophila toll have been identified in 
mammals and are referred to as TLRs (Rock et al., 1998).  
TLRs  are  cell-surface  or  endosome  membrane-bound  PRRs  able  to 
recognize  PAMPs  in  the  extracellular  space  and  intracellularly.  The  first 
human TLR identified was designated as TLR4 (Rock et al., 1998). Today, 
10 TLRs have been identified in human (TLRs 1-10) and 12 in mouse 
(TLRs 1-9 and 11-13) (Rasmussen et al., 2009). TLRs recognize a wide 
range of microbial molecules, including bacterial lipopolysaccharide (LPS) 
(TLR4),  lipids  and  carbohydrates  expressed  by  gram-positive  bacteria  
(TLR1,  2,  6),  bacterial  flagellin  (TLR5),  and  microbial  nucleic  acids 
(TLR3, 7, 8, and 9). TLRs 3, 7, 8, and 9, commonly engaged in viral 
infections (Diebold et al., 2004) (Hemmi et al., 2000), are usually expressed 
intracellularly within cytoplasmic membrane-bound compartments (Barton 
et al., 2006) (Akira & Sato, 2003). TLR-activation induces recruitment of 
adaptor molecule MyD88 and IL-1 receptor-associated kinases, which in 
turn  activate  and  trigger  mitogen-activated  protein  kinases  (MAPK)  and 
nuclear  factor  (NF)-κB  signaling  pathways  and  eventually  induce  the 
production of pro-inflammatory cytokines (Yamamoto et al., 2003).   16
 17 
 
2  Parasitic infection  
2.1  Toxoplasma gondii infection and host response 
T. gondii, an obligate intracellular protozoan parasite, was discovered 1908 
by  a  French  group  (Nicolle  and  Manceaux)  and  a  Brazilian  group 
(Spendore)(Innes et al., 2009). The parasite was isolated from a rodent in 
North Africa called Ctenodactylus gundi, which gave the parasite its name. 
The genus name, toxo, comes from the Greek word toxo, meaning arc, and 
which indicates the shape of the parasite (cresent). A unique feature of T. 
gondii is its ability to replicate in most mammalian nucleated cells and today, 
infections caused by T. gondii are considered the most prevalent and well-
studied parasitic zoonotic diseases in humans (Black & Boothroyd, 2000). It 
has  been  estimated  that  approximately  25%  of  the  human  population  is 
chronically  infected  worldwide.  In  general,  only  immunocompromised 
individuals,  for  example  HIV  patients,  suffer  from  life  threatening 
complications  such  as  toxoplasmic  encephalitis.  In  addition,  the  parasite 
could  be  transmitted  to  the  fetus  during  pregnancy,  causing  congenital 
disorders accompanied by a prominent encephalomyelitis, or stillbirth with 
hydrocephalus and retinochoroitis. Ingestion of undercooked meat or direct 
contact with cat feces are the main routes of human infection (Innes et al., 
2009) (Sibley, 2003) (Black & Boothroyd, 2000). Interestingly, the parasite 
has  been  shown  to  be  capable  of manipulating the behavior of rats, the 
intermediate  host,  in  order  to  increase  the  chance  of  being  killed  and 
ingested by cats, the definite host, thereby ensuring the completion of its 
life cycle (M. Berdoy, 2000).  
The  parasite  is  also  of  great  importance  in  the  sheep  industry.  It  is 
considered the main cause of infectious ovine abortion in Australia, New 
Zealand, the UK, Uruguay, USA, and many other countries. The neonatal 
losses in sheep flocks caused by T. gondii has been estimated to be about 1-
2% annually, which corresponds to approximately 0.5 to 1.5 million lambs 
each year in the UK and Europe, respectively, and represents a significant 
economical loss for the farmer. The infection incidence in sheep has been 
associated with contaminations of grazing land with sporulated oocysts and 
the presence of cats in the farm area. However, congenital transmission of 
the parasite from the pregnant ewe to the fetus is the most common route 
of infection. The disease outcome depends on the stage of pregnancy when 
transplacental  transmission  occurs.  An  early  infection  frequently  leads  to 
fetal death, mid-stage infection leads to stillbirth, while lambs exposed to a   18
late stage infection may be asymptomatic (Freyre et al., 1997) (Innes et al., 
2009) (Dubey, 2009). 
 
Figure 1. Toxoplasma gondii life cycle (adapted from J.P. Dubey, 1998) 
The life cycle of T. gondii (Fig. 1) involves two hosts; the definite host (cat) 
and intermediate hosts, which can be human, rodent, ruminant, or avian. 
T.  gondii  has  two  stages  of  asexual  type  in  the  intermediate  host:  a) 
tachyzoites, which rapidly multiply within the host cells via a specialized 
form of reproduction called endodyogeny (the formation of two daughter 
tachyzoites  within  the  mother).  Infected  cells  eventually  rupture  and 
tachyzoites spread to neighboring cells which then become infected (acute 
toxoplasmosis);  b)  the  bradyzoites,  which  represent  the  chronic  or  cyst 
forming  stage.  In  the  definite  host,   a  third  sexual  stage,  the 
sporozoites (oocysts), forms (Dubey et al., 1998). Ingestion of cysts by hosts 
leads  to  the  rupture  of  the  cysts  and the  release  of  bradyzoites  into  the 
intestinal epithelia where they differentiate back to the rapidly multiplying 
tachyzoite form, thereby defining the asexual part of the cycle. Ingestion of 
tissues containing cysts is the main route of infection in the cat, while the 
fecal-oral  (oocyst)  route  is  more  prevalent  in  other  hosts  (Dubey  et  al., 
1998)  (Sibley,  2004)  (Dubey,  2008)  (Black  &  Boothroyd,  2000).  The 19 
 
infection activates the host immune system, which limits the invasiveness of 
the  tachyzoites.  T.  gondii  responds  to  the  host  immune  activation  by 
formation  of  bradyzoites,  and  7-10 days  later  completes  the  formation of 
tissue cysts, which are thoroughly distributed in muscle tissues and in the 
central nervous system (Fig.1). 
2.1.1  Mechanisms of cellular entry 
Some  subgroups  of  bacteria,  such  as  Listeria  monocytogenes  (facultative 
intracellular  bacteria)  and  Chlamydia  trachomatis  (obligate  intracellular 
bacteria),  are  known  to  propagate  inside  host  cells.  The  entry  of  these 
bacteria is through the endosomal system (uptake mechanism of the cells). 
The bacteria modify the identity of the endosomes to avoid fusion with 
lysosomes,  thereby  preventing  proteolytic  processing  and  subsequent 
presentation  together  with  MHC  molecules,  and  thus  blocking  the 
establishment  of  an  adaptive  response to the infection (Gruenberg, 2006) 
(Vazquez-Boland  et  al.,  2001).  In  contrast,  T.  gondii  does  not  use  the 
endocytic machinery to penetrate, but instead uses its gliding motility to 
find  its  way  into  the  cell.  Once  inside  the  cell,  T.  gondii  forms  a  non-
fusogenic compartment termed a parasitophorous vacuole (PV), surrounded 
by  a  parasitophorous  vacuole  membrane  (PVM),  in  which  parasite 
replication takes place. In addition, PVM forms a high affinity association 
with the mitochondria and endoplasmic reticulum of the host cell, and by 
this means is believed to hinder host cell metabolism (Martin et al., 2007) 
(Sinai et al., 1997). 
2.1.2  Host immune responses to Toxoplasma gondii 
It has been shown that CD4
+ and CD8
+ T cells as well as MCs engage in 
the immune response directed towards T. gondii infection. The infection 
induces a strong innate response and expression of many different genes. 
This ultimately leads to the production of inflammatory mediators and an 
adaptive immune reaction, with production of specific antibodies, which 
kills  extracellular  but  not  intracellular  parasites.  The  acquired  immune 
response against T. gondii is characterized by strong CD4
+ and CD8
+ T cell 
activities  (Denkers  &  Gazzinelli,  1998).  The  acute  stage  of  T.  gondii 
infection is characterized by markedly elevated levels of IFN-γ and IL-12, as 
well as other pro-inflammatory cytokines such as TNF-α, IL-6, IL-1, and 
the anti-inflammatory cytokine, IL-10. These cytokines are produced by 
many  innate cells such as macrophages, dendritic cells and NK cells. Of 
these, IFN-γ was found to predominate during infection and it has been 
shown to prevent parasite colonization in many organs (Suzuki et al., 1988)   20
(Gazzinelli et al., 1991) (Ferreira et al., 2004) (Dubey, 2008). In addition, 
activated  macrophages  liberate  high  levels  of  nitric  oxide  (NO),  which 
limits replication of tachyzoites and thus reduces the immunopathological 
alterations induced by the parasite (Suzuki, 2002).  
Mice lacking MyD88 are highly susceptible to infection with T. gondii, 
suggesting  that  activation  of  TLRs  is  important  in  the  host  immune 
response  (Scanga  et  al.,  2002).  One  protein,  the  T.  gondii  profiling-like 
protein (TGPRF), was identified as a potent agonist for TLR11 in mice and 
was shown to be responsible for the potent IL-12 production by splenic 
DCs  when  stimulated  with  STag  (Yarovinsky  et  al.,  2005)  (Yarovinsky, 
2008). TGPRF remains the only T. gondii protein identified as a ligand of 
TLRs.  Moreover,  the use of parasites deficient in TGPRF revealed that 
TGPRF recognition by TLR11 is required for the infection of host cells 
and  TLR11-dependent  activation  (Plattner  et  al.,  2008).  In  addition, 
tachyzoite  surfaces  are  dominated  by  GPI  anchored  proteins,  which  are 
essential for parasite viability (Wichroski & Ward, 2003), and biochemical 
studies have shown that T. gondii GPI molecules attached to distinctive free 
lipids are recognized by both TLR2 and TLR4. In mouse macrophages, 
both  TLR2  and  TLR4  were  found  to  mediate  recognition  of  T.  gondii 
GPIs,  as  measured  by  the  induction  of  TNF-α  synthesis  (Debierre-
Grockiego et al., 2007). 
2.2   Dictyocaulus viviparus infection 
The  nematode,  D.  viviparus  belongs  to  the  parasitic  super  family 
Trichostrongyloidea.  D.  viviparus  infections  cause  great  economic  losses  to 
producers  and  to  the  livestock  economy  worldwide,  as  it  affects  young 
cattle during the first grazing season on pasture (Taylor, 2007) (Corwin, 
1997).  The  infection  is  also known as parasitic bronchitis, or verminous 
pneumonia because the main predilection sites are trachea and bronchi. The 
disease  is  distributed  worldwide  although  it  is  more  significant  in  high 
rainfall areas where the infection might persist for long time(Taylor, 2007).  21 
 
The D. viviparus life cycle (Fig. 2) starts with the first stage L1 larvae, 
which,  within  5  days  and  under  optimal  weather 
conditions differentiate into the second stage L2 larvae, and further into the 
third stage L3 larvae. Following grazing of the third stage L3 larvae (infective 
stage), the larvae penetrate the mucosa of the small intestine and continue 
migration into the mesenteric lymph node. Here, the larvae moult into the 
fourth  stage  L4 larvae  and  thereafter,  the  L4  larvae  reaches  the  lung  via 
lymph. Within a week of L3 larvae ingestion, L4 larvae can be detected in 
lung  alveoli. However, a faster migration rate has been noted when the 
infection dose increases (Poynter & Silverman, 1960). 
Figure 2. Dictyocaulus viviparus life cycle. The migration route of the life stages from third 
stage larvae to adult worms is drawn as a green line, and the route of first stage larvae is 
drawn as a red dotted line (adapted from Hagberg M, 2008, drawn by Katarina Naslund). 
The fourth stage L4 larvae develop into adult worms in lung alveoli, and 
then  migrate  to  inhabit  the  bronchial  tree.  The  eggs  produced  by  adult 
females  hatch  directly  into  first  stage  L1  larvae,  which  are  then  partly 
exhaled, re-swallowed to the gut and spread with the feces into the grazing 
field (Fig. 2) (Taylor, 2007).  
The  clinical  signs  of  disease  range  from  coughing,  nasal  and  oral 
discharge, respiratory distress, weakness and malnutrition in mild infections 
to  anorexia,  dyspnoea  and  sudden  death  in  massively  infected  calves   22
(Choquette,  1954)  (Akpavie & Pirie, 1993) (Taylor, 2007). D. viviparus 
induces  a  strong  host  immune  response  characterized  by  local  and 
circulating eosinophilia and high levels of antigen-specific IgE (Schnieder & 
Daugschies, 1993). In addition, a positive correlation between the infection 
and  total  IgE  serum  levels  (Kooyman  et  al.,  2002),  and  an  increase  in 
specific IgG1 and IgA toward D.viviparus has been described (Scott et al., 
1996).  Moreover,  a  transient  increase  in  the  proportion  of  γ/δ  TCR-
expressing T cells in bronchoalveolar lavage fluid (BALF) 2 weeks post-
infection has been reported (Hagberg et al., 2005). 
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3  Mast cell development, physiology and 
response to pathogens 
In 1878, Paul Ehrlich described a cell type located in human connective 
tissue that stained reddish-purple (referred to as metachromasia) with aniline 
dyes.  He  called  them  “mästzellen”,  a  term  that  referred  to  an  apparent 
quality of being well-fed, and was based on the appearance of numerous 
intracellular  granules  (Bloom,  1984).  The  origin  of  these  cells  remained 
obscure for many years, but Kitamura and co-workers observed that the 
WBB6F1-W/Wv  mice  (devoid  of  MCs)  developed  MCs  after  receiving 
bone marrow cells from a normal littermate. This was the first evidence that 
mouse MCs develop from bone marrow precursor cells. It is now accepted 
that MCs arise from CD34
+ pluripotential hematopoietic cells in the bone 
marrow  (Liu  et  al.,  2009)  (Sonoda  et  al.,  1983)  (Kitamura  et  al.,  1978). 
Progenitor cells were further characterized and were found to express high 
levels of c-kit and low levels of Thy-1. They were also shown to contain a 
few  cytoplasmic  granules,  and  to  express  RNAs  encoding  the  MC-
associated proteases, while lacking the expression of the high-affinity IgE 
receptor (FcεRI). In humans, MCs are also known to arise from CD34
+/c-
kit
+ progenitor cells. Isolated Thy-1
loc-kit
hi cells generated pure, functionally 
competent MC colonies at high frequencies in vitro when cultured in the 
presence of recombinant stem cell factor (SCF) and interleukin-3 (IL-3), 
but  lacked  differentiation  potential  for  other  hematopoietic  lineages.  An 
intra-peritoneal injection of this population reconstituted the peritoneum of 
genetically  MC-deficient  W/Wv  mice with functional MCs back to the 
same  levels  as  that  of  wild  type  mice  (Rodewald  et  al.,  1996).  MCs 
progenitors leave the bone marrow and circulate in blood before entering 
the  tissue  where  they  complete  their  differentiation  (Hallgren & Gurish, 
2007).  Growth  factors,  integrins,  and  chemokines,  e.g.  MCP-1/CCL2, 
MIP/CCL3,  RANTES/CCL5  all  contribute  to  MC  migration  and   24
attraction.  MCs  express  several  chemokine  receptors  such  as  CXCR2, 
CCR3, CXCR4, and CCR5, which are involved in directing the MCs 
from  the  circulation  into  the  tissue.  Furthermore,  IgE  alone  or  in 
combination with antigens can also promote the migration of MCs (Kitaura 
et  al.,  2005;  Gurish  et  al.,  2001;  Meininger  et  al.,  1992).  Mature  MCs 
resident in tissues display different functions and properties depending on 
the location, and these differences will be described below. 
3.1  In vitro studies of mast cells 
MCs,  which  are  usually  few  in  number  and  scattered  in  the  tissue  of 
interest, are difficult to purify in sufficient amounts for reliable analysis. The 
development  of  in  vitro  protocols  to  isolate  and  culture  primary  MCs, 
usually derived from bone marrow, thus proved to be very useful. The cells 
were  stimulated  with  conditioned  media  derived  from  concanavalin  A-
activated  T  cells  or  with  WEHI-3B  tumor  cell-conditioned  media,  to 
obtain virtually unlimited numbers of mouse bone marrow-derived MCs 
(BMMCs),  which  resemble  mucosal  MCs  (MMCs)  (Sredni  et  al.,  1983) 
(Nabel et al., 1981) (Nagao et al., 1981) (Razin et al., 1981) (Tertian et al., 
1981). BMMCs cultured in WEHI-3-conditioned medium as a source of 
IL-3 give rise to a population of cells, more than 85% of which express IgE-
receptors and synthesize chondroitin sulfate E and histamine after 3-5 weeks 
(Razin et al., 1984) (Rottem et al., 1993) (Metcalf, 1997). Addition of IL-4, 
IL-9 and SCF promotes proliferation and maturation of mouse BMMCs 
and peritoneal MCs (Rottem et al., 1994) (Schmitt et al., 1987) (Hultner et 
al.,  1990).  In  contrast,  culturing  of  human  cord  blood  or bone marrow 
derived mononuclear cells, in IL-3 induced the differentiation of basophils 
over MCs after 3 weeks of culture (Ishizaka et al., 1985). However, human 
peripheral blood cells cultured on medium supplemented with SCF and IL-
6 form MC colonies within 6 weeks (Saito et al., 2006). Murine BMMCs 
supplemented with IL-4 and IL-10 up-regulate mMCP-2 mRNA, which is 
characteristic of MMCs, whereas addition of SCF induces BMMCs into a 
serosal or connective tissue MC (CTMC) phenotype (Ghildyal et al., 1992) 
(Metcalf,  1997).  These  studies  implicated  that  the  maturation  of  MCs  is 
highly dependent on the local microenvironment.  
One drawback of the widely used BMMCs, however, is that they are 
fairly  immature  and  have  no  known  physiological  equivalent  in  tissues. 
Fortunately, a new method for culturing mature-differentiated serosal-type 
MCs peritoneal MC (PCMCs) was recently presented by Marc Daëron and 
co-workers (Malbec et al., 2007). These cells not only respond to IgE, but 25 
 
also to IgG antibodies through FcγRIIIA receptors. In addition, PCMCs 
contain  and  release  massive  amounts  of  preformed  granular  vasoactive 
mediators and proteases. Since murine peritoneal MCs represent <4% of 
cells recovered in peritoneal lavage from normal mice (Malbec et al., 2007), 
this  protocol  to  enable  the  collection  of  unlimited  numbers  of  mature 
CTMCs is highly useful.  
In other species, such as ovine and caprine, only a few studies have led 
to  models  for  culturing  MCs  from  bone  marrow.  By  the  use  of 
recombinant  ovine  interleukin-3  (rOvIL-3)  and  recombinant  ovine  stem 
cell factor (rOvSCF), more than 65% of the cells arising after 3 weeks in 
culture  were  MCs,  which  could  be  maintained  for  at  least  6  weeks. 
Cultured  ovine  MCs  contained  significantly  more  serine  protease  but 
similar  amounts  of  β-hexosaminidase  when  compared  with  caprine  cells 
during the second week of culture (Macaldowie et al., 1997) (Haig et al., 
1988). Stimulation of BMMCs with the calcium ionophore, A23187, led to 
dose-dependent  secretion  of  granule  constituents  and  the  generation  of 
leukotriene C4 (Huntley et al., 1992). 
3.2  Murine, human and bovine mast cell heterogeneity  
Knowledge of MC heterogeneity, first described by Enerbäck (Enerback, 
1966), arose from studies comparing MC populations in rodent cell lines. 
Based on their tissue location, granule and PG content, murine MCs can be 
divided into two major subclasses: connective tissue MCs (CTMCs) and 
mucosal  MCs  (MMCs).  The  CTMCs  can  be  found  mainly  in  the 
connective tissues of the skin and peritoneal cavity, and express tryptase, 
chymase,  carboxypeptidase  A  (CPA),  high  levels  of  heparin  PGs  and 
histamine.  In  contrast,  MMCs,  which  are  found  mainly  in  the  lamina 
propria of intestine and airways, express chondroitin sulfate (CS) PGs, and 
chymase  (Table  1)  (Miller  &  Pemberton,  2002).  Human  MCs  are  also 
divided into two major subclasses, the mucosal type MC (MCT) and the 
connective  tissue  type  MC  (MCTC),  according  to  their  protease  content 
(Table 1). MCT cells predominantly express tryptase and are usually found 
in the lamina propria of airways and in the gastrointestinal tract. MCTC cells 
express  tryptase,  chymase,  carboxypeptidase  A,  and  dominate  the 
connective tissue (Krishnaswamy et al., 2006). In a simplified comparison,  
human  MCT  cells  correspond  to  rodent  MMCs,  whereas  MCTC  cells 
correspond to rodent CTMCs (Metcalf, 1997). MC numbers in the mucosa 
of human, rat, canine, and ruminant intestines are relatively high compared 
to other species, such as mouse.    26
  Mouse 
 CTMC            MMC 
Human 
    MCT                MCTC 
Tryptase 
    mMCP-6 
mMCP-7    +  + 
Chymase      mMCP-4 
mMCP-5 
    mMCP-1 
 mMCP-2 
‒  + 
CPA  +  ‒  ‒  + 
PGs  Heparin  CS  Heparin/CS    Heparin/CS 
  Table 1.  Mast cell heterogeneity in human and mouse  
Ovine MC heterogeneity reflects the distribution of sheep MC proteinases 
(SMCP) in distinct organs such as trachea, bronchus, bronchial lymph node, 
lung,  thymus,  spleen,  liver,  flank  skin,  abomasums,  small  intestine,  and 
mesenteric lymph node. Based on reactivity to the anti-SMCP antibody, 
two  populations  of  MCs  were  defined,  one  in  gastrointestinal  tissues, 
analogous to the mucosal MC subset, and the other present in skin, the 
putative ovine connective tissue MC subset (Sture et al., 1995).  
In Bos taurus (bovine), three MC subtypes have been described: T-MC, 
expressing tryptase; TC-MC, expressing tryptase and chymase; and C-MC, 
expressing chymase. The heterogeneity and density were defined according 
to tissue location, methods of fixation (Carnoy’s fluid) and chemical staining 
in  addition  to  double-enzyme-immunohistochemical  staining  techniques. 
T-MC  was  the prevailing  subtype  in  all  investigated  organs  and  tissue 
locations. Only tryptase-positive MCs could be demonstrated in bovine skin 
and uterus, regardless of the fixation type (Kuther et al., 1998). In large 
vertebrates, the density of MCs in the peripheral bronchioles is substantially 
greater than around the conducting airways (Miller & Pemberton, 2002). 
3.3  Preformed mast cell mediators; expression and function 
Once  activated,  MCs  release  a  massive  amount  of  preformed or de novo 
synthesized mediators (Fig. 3), which are involved in many physiological 27 
 
and pathophysiological processes. The function of most of these mediators 
has only recently been understood.  
 
 
 
Figure 3. Scheme of different mast cell mediators. 
3.3.1  Histamine  
Histamine  (2-[4-imidazolyl]ethylamine)  was  discovered  in  1910  (Dale  & 
Laidlaw, 1910) and in 1932 it was identified as a mediator of anaphylactic 
reactions  (Maintz  &  Novak,  2007).  Histamine  belongs  to  the  biogenic 
amines  and  is  synthesized  from  the  amino  acid  histidine  by  L-histidine 
decarboxylase  (HDC).  In  addition  to  MCs  and  basophils, which are the 
main  source  of  histamine  in  the  body,  synthesis  of  histamine  occurs  in 
platelets, histaminergic neurons, and enterochromaffine cells (Riley & West, 
1952) (Ishizaka et al., 1972). In MCs and basophils, histamine is stored in 
secretory  granules,  associated  by  ionic  linkage  at  acidic  pH  with  the 
carboxyl groups of proteins and PGs. Binding of histamine to the histamine 
receptors, H1R, H2R, H3R, and H4R exerts variable effects on target cells 
in various tissues, such as smooth muscle cell contraction, vasodilatation, 
increased vascular permeability and mucus secretion, tachycardia, and gastric 
secretion.  MCs  also  express  histamine  receptors  H1R,  H2R,  and  H4R 
indicating  an  autocrine/paracrine  activation  mechanism  (Lippert  et  al., 
2004).  Mice  deficient  in  HDC  showed  a  decrease  in  MC  numbers  and   28
decreased storage of PGs and proteases in MC granules compared to normal 
mice (Ohtsu et al., 2001). 
3.3.2  Tryptases 
Tryptase, with trypsin-like activity, is one of the major constituents of MC 
granules, and belongs to the serine protease family. Human MCs express 
two classes of tryptases, known as α (with variants αI and αII) and β (with 
variants  βI,  βII and βIII) (Pallaoro et al., 1999) (Miller et al., 1989). In 
addition,  human  MCs  express  a  transmembrane  tryptase,  γ-tryptase  or 
hTMT,  which  seems  to  be  exposed  on  the  cell  surface  after  MC 
degranulation, and another tryptase, the δ-tryptase, with as yet unknown 
biological function (Caughey et al., 2000) (Wong et al., 2002). 
 In contrast, murine MC tryptase expression seems to be restricted to 
CTMCs. CTMC tryptases so far described in mouse are mMCP-6 and -7, 
where the expression of the latter is strain dependant, e.g. C57BL/6 strain 
does  not  express  mMCP-7  because  of  a  mutation  affecting  a  splice  site 
(McNeil et al., 1992; Reynolds et al., 1991). Mouse MCs also express a 
transmembrane  form  of  tryptase,  mTMT  (Wong  et  al.,  1999),  and  a 
tryptase-like enzyme known as mMCP-11, which was mainly expressed at 
early stages of MC differentiation, in a similar to mMCP-7 (Wong et al., 
2004). Rat MMCs, like their murine counterparts, do not express tryptases, 
but rather express several members of the rMCP-8 family such as (rMCP-8, 
-9,  and  -10),  a  protease  family  of  unknown  substrate  specificity  and 
biological  function.  Further,  rat  CTMCs  were  found  to  express  two 
tryptase genes, rMCP-6 and -7 (Lutzelschwab et al., 1997). 
 In sheep, two tryptases have been described, tryptase-1 and -2, as well as 
two  other  MC  proteases,  sMCP-1  and  -3  (Pemberton  et  al.,  2000) 
(McAleese  et  al.,  1998).  Two  similar  bovine  MC  tryptases,  bovine  lung 
tryptase (BLT) and bovine liver capsule tryptase (BLCT) have been isolated 
from  lung  and  liver,  respectively  (Gambacurta  et  al.,  2003).  Dogs  also 
express a tryptase, known as mastin (Raymond et al., 2005) (Vanderslice et 
al., 1989). 
Activation  
MC  proteases,  including  tryptases,  are  synthesized  in  preproform  in  the 
endoplasmic reticulum. A subsequent cleavage process leads to generation of 
the proforms, propeptide, and the mature enzymes. Dipeptidyl peptidase I 
DPPI (cathepsin C) may be involved in the processing of the N-terminal 
dipeptide  of  prochymases  (Pejler  et  al.,  2007),  which  was  supported  by 
studies in the DPPI
-/- mouse, which fail to generate active chymases in vivo. 29 
 
The N-terminal processing mechanism was less characterized for tryptases. 
However, the level of mature tryptases was lower in DPPI
-/- MCs than in 
wild type counterparts. All MC proteases, including tryptase, are stored as 
fully  processed  enzymes,  in  contrast  to  some  other  enzymes.  MCs, 
therefore, most likely need a protective system to overcome any protease 
leakage  from  granules  to  the  cytoplasm.  The  serpin  class  of  protease 
inhibitors have been proposed as one potential protective mechanism (Pejler 
et al., 2007; Wolters et al., 2001). Tryptase in MC granules is stored as an 
active tetramer in complex with SGPG, with an active site facing a central 
pore.  Dissociation  of  this  tetrameric  structure  might  result  in  inactive 
monomers. Additionally, previous studies have also shown that tryptase can 
be active in the monomeric form (Schwartz & Austen, 1980) (Schwartz & 
Bradford, 1986) (Schwartz et al., 1981) (Hallgren et al., 2001) (Addington & 
Johnson, 1996).  
Function  
Immunologically, MC tryptases are implicated in a variety of inflammatory 
disorders.  The  prominent  proinflammatory  role  in  allergies  has  been 
extensively  studied  in  humans  as  well  as  in  animal  models  of  allergic 
inflammation (Caughey, 2007). Injection of human tryptase into guinea pig 
or recombinant mMCP-6 into mice induced the influx of neutrophils and 
eosinophils into skin and peritoneum, mediating peritonitis (Huang et al., 
1998), and increased microvascular leakage in the skin (He & Walls, 1997). 
Tracheal administration of human tryptase βI to MC-deficient mice was 
shown to have a protective role against Klebsiella pneumoniae infection in the 
lung (Huang et al., 2001), and conversely, inhibition of MC tryptases in 
inflammatory arthritis was found to have a therapeutic effect (McNeil et al., 
2008).  MC  tryptases  can  activate  protease-activated  receptors  (PAR2), 
which leads to inflammation in the airways, joints and kidney, degrading 
fibrinogen  and  thereby  limiting  blood  clot  formation  (Ossovskaya  & 
Bunnett, 2004).  Additionally, tryptases have been shown to play a role in 
many  other  physiological  functions  and  diseases  such  as  fibrosis, 
angiogenesis, itching, sepsis, multiple sclerosis, tissue remodeling, arthritis 
and sudden infant death syndrome (Fiorucci & Ascoli, 2004) (Pejler et al., 
2007) (Shin et al., 2009).  
3.3.3  Chymases 
MC  chymases  with  chymotrypsin-like  activity  also  belong  to  the  serine 
protease  family  (Benditt  &  Arase,  1959). Expression profiles vary among 
MC  subtypes  and  species.  Humans  express  only  one  chymase  gene   30
belonging to the α-family expressed by MCTC cells (Caughey et al., 1991) 
(Urata et al., 1991). Murine MCs express several chymases: MMCs express 
two  chymases  belonging  to  the  β-family designated as mMCP-1 and -2 
(Chu  et  al.,  1992)  (Serafin  et  al.,  1990)  (Chu  et  al.,  1992).  In  addition, 
CTMCs express mMCP-4 (β-chymase), mMCP-5 (α-chymase, but with 
elastase  like  activity)  and  mMCP-9  (particularly  uterine  MCs).  It  is 
noteworthy that mMCP-4 constitutes the major chymotrypsin-like activity 
in peritoneum and ear connective (Pejler et al., 2007) 
Activation 
Like the tryptases, the MC chymases are synthesized as inactive proproteins 
and are activated intracellularly by the enzyme, DPPI (Wolters et al., 2001). 
Active MC chymases are then stored in low pH secretory granules in a tight 
complex  with  serglycin  PGs.  In  a  neutral  environment,  chymases  are 
known  to  cleave  peptides  at  specific  locations  in  polypeptide  chains 
following aromatic amino acids (Powers et al., 1985). 
 
Function   
Previous work from our lab showed that mMCP-4 (which together with 
CPA is involved in the formation and degradation of angiotensin II) plays a 
key  role  in  the  activation  of  pro-matrix  metalloprotease-9,  as  well  as  in 
thrombin regulation and fibronectin turnover (Tchougounova et al., 2005) 
(Lundequist et al., 2004) (Tchougounova et al., 2003).  We further showed 
that  mMCP-4  contributes  to  the  antibody  response  and  severity  in 
autoimmune arthritis (Magnusson et al., 2009), and that it has a protective 
role  in  inflammation  of  the  airways  induced  by  allergens  (Waern  et  al., 
2009). Prominent roles in the regulation of homeostatic intestinal epithelial 
migration  and  barrier  function  during  inflammatory  conditions,  and  in 
aneurysm formation has also been described (Groschwitz et al., 2009) (Sun 
et al., 2009).  
3.3.4  Carboxypeptidase A 
In 1979, MC carboxypeptidase A (MC-CPA) was partially purified from rat 
liver  mitochondria,  and  was  thought  to  reside  in  the  inner  surface  of 
mitochondrial membranes, although an MC origin was also suggested (Haas 
& Heinrich, 1979). Normally, CTMCs express MC-CPA with a molecular 
weight   of 30-35 kDa in human, mouse and rat (Goldstein et al., 1987) 
(Serafin et al., 1987) (Everitt & Neurath, 1980). Murine MC-CPA is a zinc-
dependent  metalloprotease  with  exoprotease  activity  that  hydrolyzes  C-
terminal  residues  with  aliphatic  or  aromatic  amino  acids.  MC-CPA  was 31 
 
found  to  form  a  macromolecular  complex  with  PGs  in  the  secretory 
granules. In human, MCTC cells appear to be the source of MC-CPA, and it 
thus has similar tissue distribution in both rodents and humans (Irani et al., 
1991). Positively charged amino acids in MC-CPA are thought to mediate 
CPA storage of MC-CPA in MC granules through high affinity interactions 
with  the  negatively  charged  serglycin  PGs  containing  heparin,  or 
chondroitin sulfate. Storage is highly dependent on heparin and MC-CPA 
storage and processing was shown to be altered in mice deficient in N-
deacetylase/N-sulfotransferases  2  (NDST-2),  the  downstream  enzyme  in 
heparin  synthesis  (Humphries  et  al.,  1999)  (Henningsson  et  al.,  2002) 
(Forsberg et al., 1999). Storage of MC-CPA was also found to be defective 
in SG-deficient mice (Abrink et al., 2004). Like tryptase and chymase, MC-
CPA  is  stored  as  an  active  form  with  lowered  enzymatic  activity 
(Henningsson et al., 2002). 
Activation  
The  preproenzyme  of  MC-CPA  in  both  mouse  and  human  consists  of 
about 417 amino acids, with a 15 amino acid N-terminal signal peptide and 
a 94 amino acid activation peptide. Activation produces a mature MC-CPA 
of 308 amino acids (Reynolds et al., 1989b) (Reynolds et al., 1989a). Work 
performed  in  mice  deficient  in  cathepsin  E  showed  that  cathepsin  E  is 
important for MC-CPA processing (Henningsson et al., 2005). Storage of 
MC-CPA  and  mMCP-5  was  strongly  correlated  in  MC-CPA  knockout 
mice.  The  MC-CPA  deficient  strain  was  also  deficient  in  mMCP-5, 
although other proteases, such as mMCP-4 and mMCP-6 were not affected 
(Feyerabend et al., 2005).  
 
Function  
MC-CPA  is  implicated  in  endothelin-1  (ET-1)  degradation.  ET-1  is  a 
major  vasoconstrictor  and  plays  an  important  role  in  sepsis.  However, 
addition of CPA inhibitors did not inhibit the degradation of ET-1 (Maurer 
et al., 2004), suggesting that other MC-derived proteases possibly contribute 
to  this  process.  MC-CPA  has  also  been  reported  to  reduce  snake  and 
honeybee  venom-induced  pathology,  by  degrading  certain  snake  venom 
components and reducing honeybee venom morbidity and mortality (Metz 
et al., 2006).   
3.3.5  Proteoglycans (PGs) 
PGs comprise a wide range of ubiquitously distributed macromolecules and 
structural diversity suggests involvement in a multitude of functions. PGs   32
are  also  found  in  more  simple  organisms,  such  as  Drosophila  spp.  and 
Caenorhabditis  elegans  (Kolset  &  Tveit,  2008).  The  influence  of  PGs  on 
biological processes is mediated through interaction with a huge variety of 
proteins and components of the extracellular matrix (ECM) (Handel et al., 
2005) (Iozzo et al., 1994).  
 
 
Figure 4. Classes of proteoglycans  
Glycosaminoglycan  (GAG)  chain  biosynthesis  takes  place  in  the  Golgi 
apparatus and comprises a multi-step enzymatic process. Depending on cell 
type  and  location  in  the  tissue,  GAG  chains  attached  to  PGs  can  vary. 
GAGs  can  be  grouped  into  three  main  classes  known  as  heparan 
sulfate/heparin,  keratan  sulfate,  and  chondroitin  sulfate/dermatan  sulfate. 
PGs can be located at the cell surface, e.g. syndecans and glypicans, the 
extracellular  matrix,  e.g.  perlecan  and  agrin,  and  intracellularly,  e.g. 
serglycin  proteoglycans  (SGPG)  (Esko  &  Lindahl, 2001)  (Lindahl et al., 
1998) (Fig. 4). Interestingly, hyaluronic acid (hyaluronan), the non-sulfated 
form of GAGs, is not attached to any core protein. Hyaluronan was shown 
to be expressed in rodent and human skin MCs (Eggli & Graber, 1993). In 
addition, it was demonstrated earlier that MC granules are a rich source of 33 
 
hyaluronan, suggesting that hyaluronan is possibly involved in pathological 
processes in asthma and allergy (Soderberg et al., 1989). 
Synthesis of glycosaminoglycans (GAGs) 
PGs consist of a protein core with long covalently attached, un-branched 
and negatively charged polysaccharide chains, or GAGs. The GAG chains 
are  composed  of  repeated  disaccharide  units  made  up  of  one  alternating 
amino  sugar,  N-acetylgalactosamine  (GalNAc)  or  N-acetylglucosamine 
(GlcNAc), bound to either hexuronic acid (HexA) or galactosamine (Gal) 
(Fig. 5). Attachment of the sugar chains to the core protein occurs through 
an O-glycosidic bond, usually to serine or threonine residues (Bernfield et 
al.,  1999)  (Kjellen  &  Lindahl,  1991).  The  first  polymerization  step  in 
CS/DS and heparin/HS chain PG synthesis is the formation of the linker 
tetrasaccharide region (xylose-galactose-galactose-GlcA), followed by chain 
elongation by alternating addition of GalNAc and glucuronic acid (GlcUA), 
driven  by  chondroitin  sulfate  polymerase  in  the  case  of  CS  and 
EXT1/EXT2 in the case of heparin/HS (Fig.5) (Lind et al., 1998).  
Figure 5. Heparin/heparin sulfate and chondroitin sulfate biosynthesis (modified from Prydz 
et al., 2000).  
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Other  modifications  occur  by  the  action  of  N-deacetylase/N-
sulfotransferases (NDSTs), C5-epimerase and 2, 3, and 6 O-sulfotransferase 
enzymes that introduce sulfate groups at various positions, and which finally 
result in the production of a highly sulfated heparin or the less sulfated HS 
(Prydz & Dalen, 2000) 
Until recently, four isoforms of the NDST enzyme family have been 
identified in mice; NDST-1 and NDST-2 are expressed in embryonic and 
adult  tissue,  whereas  NDST-3  and  NDST-4  are  principally  expressed 
during embryogenesis (Aikawa et al., 2001) (Eriksson et al., 1994). Heparin 
is mainly expressed by CTMCs. Genetic targeting of the genes encoding 
the  enzymes,  NDST-2  and  NDST-1,  demonstrated  that  NDST-2  is 
essential for heparin biosynthesis whereas NDST-1 is essential for heparan 
sulfate synthesis (Forsberg et al., 1999) (Ringvall et al., 2000).   
 
Function  
The syndecans, which are transmembrane HSPGs, possess an extracellular 
domain with GAG-attachment sites on that side. Mammalian cells express 
four types of syndecans, syndecans 1 to 4 (Saunders et al., 1989), and nearly 
all cells express at least one type (Kim et al., 1994). Syndecans are involved 
in  cell-cell,  cell-matrix  adhesion  and  signaling,  and  syndecan-1  has  been 
shown to bind a broad range of extracellular proteins, via its HS chains, thus 
serving  as  a  matrix  receptor.  Glypicans  constitute  another  family  of  cell 
surface PGs that carry HS GAG chains, which are linked to the cytoplasmic 
membrane through a GPI anchor. In mammals, this family consists of six 
members, glypicans 1 to 6 (Saunders et al., 1997) (David, 1993).  
Perlecan,  located  in  all  basement  membranes  and  many  other 
extracellular matrices, is one of the most well studied extracellular PGs. The 
perlecan core protein can interact with fibronectin, laminin, growth factors 
and cytokines (Isemura et al., 1987). Agrin is a molecule that plays a key 
role in the aggregation of acetylcholine receptors during the development of 
the neuromuscular junction during embryogenesis (Nitkin et al., 1987). 
3.3.6  Serglycin proteoglycan   
Serglycin proteoglycan (SGPG), the first gene for the core protein of a PG 
to be cloned (Bourdon et al., 1985), was initially disclosed as a secretory and 
membrane associated product isolated from a rat L2 yolk sac carcinoma cell 
line (Oldberg et al., 1981), and was found to be expressed in a broad range 
of cells of hematopoietic origin (Tantravahi et al., 1986). The SG gene from 
mouse and human consists of three exons (Avraham et al., 1989), which 
seems to be the conserved genomic structure in most species (Genbank, 35 
 
2010).  Exon  1  encodes  for  the  first  25  amino  acid  residues,  which 
encompass the signal peptide of the core protein, exon 2 encodes for the N-
terminal part of the protein and exon 3 encodes a 79 amino acid sequence 
that  contains  the  GAG  attachment  site,  i.e.  the  serine/glycine  repeats. 
SGPG  is  the  dominating  PG  identified  in  secretory  granules,  but  is 
constitutively secreted in some cell types. The GAGs attached to SGPGs, 
with different sulfation patterns, are chondroitin 4-sulfate, chondroitin 6-
sulfate, chondroitin 4, 6-sulfate, HS or heparins, depending on the cell type 
in which SG is expressed. Heparin is considered to be the most negatively 
charged  GAG  in  vivo  (Kolset  &  Gallagher,  1990).  In  c-kit  ligand/SCF-
induced growth of MCs, heparin links to the SG protein core, whilst IL-3-
induced  growth  leads  to  chondroitin  4,6-sulfate  linkage  to  the  SG  core 
protein  (Levi-Schaffer  et  al.,  1986)  (Razin  et  al.,  1982).  The  sulfation 
pattern of the GAG chains influences their biological functions, e.g. MCs 
and basophils contain highly sulfated GAG chains, whereas NK cells and 
CTLs  posses  less  sulfated  GAG  chains.  Interestingly,  the MC  subtypes, 
CTMCs  and  MMCs,  express  different  types  of  GAGs.  Mouse  CTMCs 
contain SG-heparin, whereas mouse MMCs contain SG-CS (Enerback et 
al., 1985). On the other hand, human MCs seem to express both GAG-
types in the same MC-subclass (Stevens et al., 1988).  
3.3.7  Functional consequences of serglycin-deficiency 
Previous work on NDST-2-deficient mice showed an impairment in the 
storage of the MC-specific proteases, MC-CPA, mMCP-4, mMCP-5 and 
mMCP-6(Forsberg  et  al.,  1999;  Humphries  et  al.,  1999).  Furthermore, 
mMCP-6  was  dependent  on  heparin  for  the  formation  of  functional 
tetramers,  and  the  mMCP-4-heparin  complex  was  shown  to  play  an 
important  role  in  extravascular  coagulation    (Hallgren  et  al.,  2000) 
(Tchougounova & Pejler, 2001) (Tchougounova & Pejler, 2001). In line 
with  these  results,  the  deletion  of  the  SG  gene,  which  also  produced 
knockout mice with normal development and fertility, showed that SGPGs 
had a profound impact on MC granule hemostasis (Abrink et al., 2004). 
Briefly, this work showed that many of the MC-proteases, such as mMCP-
4, -5, -6, and MC-CPA were highly dependent on SGPGs for their storage 
in CTMCs, although SG was not essential for the expression of protease 
mRNA. The lack of dependence of other proteases on SG for storage was 
also discussed, e.g mMCP-1 and mMCP-7 were not dependent on SG for 
storage,  whereas  mMCP-2  was  partially  SG-dependent.  The  SG-
dependency for storage was mostly attributed to the electrostatic nature of 
the  protein  surfaces,  where  positively  charged  proteases  interact  with   36
negatively charged PGs (Braga et al., 2007). CTLs failed to store granzyme 
B and were impaired in their ability to produce secretory granules of high 
density  (Grujic  et  al.,  2005).  In  addition,  neutrophil  elastase,  a  protease 
present in the azurophil granules of neutrophils, was lacking in SG-deficient 
neutrophils (Niemann et al., 2007).  
The  correct  packaging  of  granule  components  such  as  hormones, 
peptides, and other enzymes into secretory granules is crucial for the proper 
assembly of a functional secretory vesicle. Correctly packed, the granule will 
appear  dark  and  dense  in  electron  micrographs.  Immunocytochemical 
studies of MC chymase and tryptase in association with SG suggested that 
chymase may be located in the electron-dense parts while tryptase is located 
in  the  translucent  parts  of  secretory  vesicles  (Whitaker-Menezes  et  al., 
1995). However, in IL-3-derived BMMCs, the lack of SG did not interfere 
with the formation of functional secretory vesicles. Formation of the dense 
core  was  defective,  and  it  was  suggested  that  SG  was  involved  in  the 
retention of proteases after entry into the secretory vesicles (Henningsson et 
al., 2006). Together, these studies clearly demonstrated that SG is important 
in the process of granulopoiesis, i.e. in the generation of storage granules.  
 
3.4  De novo-synthesized mast cell mediators 
3.4.1  Lipid mediators, leukotrienes and prostaglandins 
Leukotrienes were identified in the late 1970s (Murphy et al., 1979).  They 
are a family of inflammatory lipid mediators synthesized from arachidonic 
acid  by  various  cell  types,  including  MCs,  eosinophils,  neutrophils, 
basophils,  and  macrophages.  The  cleavage  of  arachidonic  acid  from  the 
nuclear membrane by phospholipase A2 (PLA2) initiates the synthesis of the 
leukotrienes (Uozumi et al., 1997). Interaction of arachidonic acid with the 
biosynthetic proteins, 5-lipoxygenase (5-LO) and 5-lipoxygenase activating 
protein (FLAP), results in the formation of the intermediate, 5-HPETE (5-
hydroxyperoxy-6,  8,  11,  14-eicosatetraenoic  acid),  which  is  quickly 
converted  to  LTA4.  LTA4  hydrolase  or  LTC4  synthase  then  converts 
LTA4 into LTB4 or LTC4, respectively. LTC4 is converted extracellularly 
to LTD4 and LTE4 by sequential amino acid removal from the glutathione 
tripeptide moiety. Thus, LTC4, LTD4, and LTE4 are together referred to 
as  cysteinyl  leukotrienes  (CysLTs).  CysLTs  exert  their  actions  through 
activation  of  two  receptors,  CysLT  subtype  1  receptor  (CysLT1)  and 
CysLT subtype 2 receptor (CysLT2). LTE4 is the most stable form of the 37 
 
CysLTs, and accordingly, can be measured in the urine. LTE4 is often used 
as  a  marker  of  ‘whole  body’  leukotriene  synthesis.  A  complex  inter-
regulation between CysLTs and a variety of other inflammatory mediators 
exists, where CysLTs are believed to play roles in the maturation and tissue 
recruitment of inflammatory cells. CysLT1 has been suggested as a potential 
drug target (Peters-Golden et al., 2006). 
Prostaglandins  are  produced  through  the  activity  of  cyclooxygenase 
(COX)  on  arachidonic  acid.  The  major  COX  product  in  MCs  after 
allergen-induced activation is prostaglandin D2 (PGD2) (Lewis et al., 1982). 
Besides  being  a  potent  inhibitor  of  platelet  aggregation,  PGD2 
is chemotactic  for  human  neutrophils,  and  together  with  LTD4, may 
mediate the accumulation of neutrophils in human skin (Metcalf, 1997).  
3.4.2  Platelet activating factor (PAF) 
The name refers to its ability to aggregate and degranulate platelets, besides 
many  other  biological  activities.  PAF  has  been  shown  to  induce 
bronchoconstriction,  most  likely  through  contraction  of  airway  smooth 
muscles,  to  constrict  blood  vessels,  and  to  increase  endothelial  cell 
permeability.  Furthermore,  PAF  is  proinflammatory,  i.e.  chemoattractant 
for eosinophils, neutrophils, and lymphocytes, and activates eosinophils and 
neutrophils, inducing the release of granule- associated and newly formed 
mediators (Hines, 2002). 
3.4.3  Mast cell-derived cytokines and chemokines 
Plaut et al. were the first to demonstrate that murine MCs are capable of 
expressing  many  cytokines  (Plaut  et  al.,  1989).  Since  then,  others  have 
shown that MCs express a spectrum of cytokines and chemokines, such as 
interleukin (IL)-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8, IL-9, IL-12, IL-13, 
IL-16,  tumor  necrosis  factor  (TNF-α),  interferon  (IFN-γ), 
granulocyte/macrophage  colony-stimulating  factor  (GM-CSF),  monocyte 
chemotactic protein 1 (MCP- 1), and macrophage inflammatory proteins 
(MIP) 1 and 2 (Hines, 2002) (Nakano et al., 2007), in response to IgE, 
TLR,  or  substance  P  activation  (Bradding  &  Holgate,  1996)  (Bradding, 
1996). The release of cytokines and chemokines can also be induced by 
factors that do not cause degranulation, including lipopolysaccharides, stem 
cell factor, thrombin, and nerve growth factor (NGF). In human, IL-4 is 
preferentially  expressed  by  MCTC  cells,  whereas  IL-5  and  IL-6  were 
generally restricted to the MCT subset. Furthermore, MCs have been shown 
to produce IL-16 and the chemokine, lymphotactin, both contributing to 
lymphocyte recruitment at sites of MC degranulation (Metcalf, 1997).    38
The proinflammatory cytokine, TNF-α, has been shown to be stored in 
the secretory granules and released upon activation, and is thus classified as 
one of the preformed mediators (Walsh et al., 1991). TNF-α is a multi-
functional cytokine involved in leukocyte extravasation through regulation 
of endothelial leukocyte adhesion molecule-1 (Messadi et al., 1987). 
3.5  Mast cell activation and function 
In order to release their mediators and become functional, MCs need to be 
activated by one of many different pathways. Activation of MCs through 
FcεRI and its ligand, IgE, is still among the most extensively studied.  In 
addition, TLRs and FcεRI were found to induce rapid and selective MC 
activation.  However,  other  pathways  for  MC  activation  have  been 
recognized and need to be discussed (Fig. 6). 
 
 
 
Figure 6. Different mechanisms of mast cell activation  
3.5.1  IgE-dependant mast cell activation 
The most well studied event of MC activation is via antigen-crosslinked 
IgE/FcεRI  receptors,  which  is  a  crucial  event  in  type  I  hypersensitivity 
reactions (Gilfillan & Tkaczyk, 2006). The FcεRI on MCs includes three 39 
 
subunits: FcεRIα, FcεRIβ, and FcεRIγ (Gilfillan & Tkaczyk, 2006) (Rivera 
& Gilfillan, 2006). IgE is bound to the α-chain through its Fc domain (Lin 
et al., 1996), thereby securing attachment to the MC surface. Crosslinking 
triggers activation of the kinase, Lyn, which in turn phosphorylates FcεRI 
ITAMs  (immunoreceptor  tyrosine-based  activation  motifs)  followed  by 
downstream activation processes for many enzymes and adaptor-molecules 
and leading to MC degranulation (Kalesnikoff & Galli, 2008). Interestingly, 
murine  MCs  exposed  to  a  high  level  of  IgE  in  the  absence  of  specific 
antigen  increased  surface  expression  of  their  FcεRIs  and,  subsequently 
increased mediator release after activation by cross-linking of surface-bound 
IgE  by  allergen.  Thus,  IgE  not  only  mediates  MC  activation,  but  also 
regulates MC functions by itself (Kawakami & Galli, 2002).  
3.5.2  IgG-regulated activation 
Surprisingly,  IgE-deficient  mice  were  found  to  exhibit  anaphylaxis, 
suggesting  another  mechanism,  presumably  mediated  via  IgG/Fcgamma 
receptors,  to  compensate  for  IgE  deficiency  (Oettgen  et  al.,  1994).  In 
support  of  this,  murine  MCs  do  express  low  affinity  receptors  for  IgG, 
including FcγRIIb1, FcγRIIb2 and FcγRIII (Benhamou et al., 1990) (Katz 
&  Lobell,  1995).  Of  those,  FcγRIII  has  been  revealed  to  induce  MC-
degranulation  (Katz  &  Lobell,  1995)  and  promote  adhesion  after  IgG- 
mediated aggregation (Dastych et al., 1997). Peritoneal mouse MCs were 
found  to  express  receptors  capable  of  binding  mouse  monoclonal  IgG1, 
IgG2a, and IgG2b, but not IgG3 antibodies (Tigelaar et al., 1971). Other 
FcγRs  such  as  FcγRIIB  and  FcγRIIIA  were  also  found  to  bind  IgE 
aggregates or complexes. Human MCs were demonstrated to express FcγRI 
(CD64)  following  IFN-γ  treatment  (Okayama  et  al.,  2000).  In  addition, 
aggregation of FcγRI on the surface of human MCs induced degranulation, 
generation  of  arachidonic  acid-derived  mediators,  and  up-regulatation  of 
cytokine and chemokine mRNAs (Malbec & Daeron, 2007). 
3.5.3  Complement receptor-mediated activation 
MCs have long been recognized to interact with the complement system: 
C3a and C5a, for example, activate MCs through complement receptors 
CR3  (CD11b)  and  CR4  (CD11c).  Constitutive  expression  in  MC 
populations  is  low  and  expression  is  up-regulated  only  after  cellular 
activation. Furthermore, the expression levels of complement receptors also 
varies depending on the differentiation status of the MCs and the effects of 
local  cytokines.  In  humans,  the  C5aR  was  observed  to  be  expressed  by 
some  skin  and  cardiac  MCs  but  not  by  MCs  from  the  uterus,  lungs  or   40
tonsils, which indicates that MCs from different anatomical locations might 
vary in their capacity to respond to complement components (Fureder et al., 
1995). In addition to their function as MC activating agents, C3a and C5a 
have been shown to be chemotactic for MCs (Nilsson et al., 1996). In a 
mouse model of bacterial infection by caecal ligation and puncture, both 
C3
-/- and C4
-/- mice were more susceptible to infection, and these mice also 
showed reduced MC activation during peritoneal infection (Prodeus et al., 
1997).  
3.5.4  Toll-like receptor activation 
Numerous studies report the expression of TLR1 to TLR9 in murine MC 
populations (Mrabet-Dahbi et al., 2009). Through the expression of TLRs, 
MCs are able to recognize different PAMPs, For example, TLR4 recognizes 
and responds to lipopolysaccharide (LPS), a cell wall component of gram-
negative bacteria (Zhang et al., 2004) (Supajatura et al., 2001), and TLR2 
recognizes  peptidoglycan,  a  constituent  of  the  cell  wall  of  gram-positive 
bacteria  (Takeda  et  al.,  2003).  In  addition, TLR3  mediated  activation  of 
fetal  skin-derived  mouse  MCs  and  cultured  human  MCs,  inducing  pro-
inflammatory  cytokine  production  and  type  I  IFNs,  respectively 
(Matsushima et al., 2004) (Kulka et al., 2004). TLR1 and TLR6, which 
form functional heterodimers with TLR2, are also expressed by rodent and 
human  MCs,  and  TLR7  and  TLR8  are  crucial  for  responses  to  single-
stranded RNA sequences associated with viral infection (Marshall, 2004). 
The  interaction  between  PAMPs  and  TLRs  on  MCs  cause  activation, 
induction  of  expression  and  release  of  cytokines,  leukotrienes  and 
prostaglandins (Marshall, 2004; Okumura et al., 2003). 
3.5.5  Other mast cell activators  
MCs  are  also  activated  by  other means, such as substance P, compound 
48/80,  mastoparan,  polymyxin  B,  peptides  such  as  melitin  (bee  venom 
peptides)  and  adrenocorticotropic  hormone  (ACTH),  which  can  cause 
histamine release. Certain cytokines and chemokines, such as IL-1, IL-3, 
SCF,  GM-CSF,  macrophage  inflammatory  protein-1  (MIP-1)  and 
monocyte  chemoattractant  peptide-1  (MCP-1),  are  also  able  to  elicit  a 
response (Mekori & Metcalfe, 2000). In addition, cell-to-cell interactions, 
opiates, calcium ionophores, endothelin, adenosine, as well as physiological 
stress such as changes in osmolarity, pressure and UV light can also provoke 
MC activation (Metcalf, 1997). 41 
 
3.6  Mast cell function 
Tissue-resident MCs are large, round cells scattered throughout the body, 
close to external and internal surfaces such as skin, airways, mucosa, and 
blood  vessels  (Bischoff  et  al.,  2000).  MCs  exert  physiological  and 
pathopysiological functions at these strategically important sites (Maurer et 
al.,  2003).  MCs  are  mostly  associated  with  allergy  and  anaphylaxis,  but 
have also been shown to play a key role in innate immunity through the 
regulation  of  the  inflammatory  response  and  to  possibly  link  innate  and 
adaptive  immunity.  MCs  contribute  to  allergic  inflammation  through  a 
variety of complex events, including the synthesis and release of mediators 
such  as  histamine  and  serotonin.  Cross-linking  of  FcεRI  receptors  by 
specific allergens, as well as neuropeptides, complement factors, cytokines, 
hyperosmolarity, lipoproteins, adenosine, superoxidases, hypoxia, chemical 
and physical factors (extreme temperatures, traumas), or alcohol and certain 
food and drugs, have been shown to activate MCs and induce the release of 
histamine (Maintz & Novak, 2007) (Vlieg-Boerstra et al., 2005).  
The  physiological  sequels  for  releasing  these  mediators  are  increased 
vasodilatation, local secretion by mucosal tissues, and an increase in smooth 
muscle  reactivity  In  addition,  MCs  are  also  involved  in  bidirectional 
communication with nerves through the release of MC mediators and the 
capacity to respond to factors released by the nerves (Maurer et al., 2003). 
Further, MCs have been suggested to play a role in various contexts, such as 
peripheral  tolerance,  phagocytosis  of  pathogens,  endocrine  function, 
metabolism  of  lipid/vitamins/calcium,  tissue  growth,  response  to  stress, 
aging, protection from cancer, and in autoimmune diseases such as multiple 
sclerosis, bullous pemphigoid, and rheumatoid arthritis (Fig. 7).  MCs are 
intimately  involved  in  maintaining  blood  vessel  tone,  blood  pressure 
regulation,  vascular  permeability,  and  angiogenesis  (Gregory  &  Brown, 
2006; Maurer et al., 2003) (Galli et al., 2005). Furthermore, MCs in the gut 
have been shown to play important roles in multiple organ function such as 
fluid  and  electrolyte  secretion  by  epithelial  cells  and  motor  functions  of 
smooth muscle cells (Crowe et al., 1997)(Fig.7). Additionally, as a source of 
heparin, MCs could possibly regulate blood coagulation (Tchougounova & 
Pejler, 2001) (Sillaber et al., 1999). Finally, the recruitment of MCs to sites 
of  tissue  repair  and  fibrosis  also  suggest  involvement  in  these  processes 
(Metcalf, 1997).   42
 
Figure 7. The hypothesized physiological and pathophysiological roles of mast cells. 
3.7  Mast cells and infection 
Both human and mouse MCs have been shown to be capable of presenting 
antigens through MHC class I- and MHC class II-dependent pathways in 
vitro (Poncet et al., 1999) (Malaviya et al., 1996b). Moreover, MCs may 
indirectly  present  antigen  by  internalization  of  IgE-bound  antigen  for 
presentation to specific T cells (Kambayashi et al., 2008). The release of 
MC-specific mediators after activation seems to be crucial for initiating an 
efficient early response at sites of infection. The release of cytokines, such as 
TNF-α  and  the  protease  mMCP-6,  induces  recruitment  of  neutrophils, 
resulting in pathogen clearance and can improve survival in mice during 
septic peritonitis (Malaviya et al., 1996a) (Henz et al., 2001) (Marshall, 2004; 
Echtenacher et al., 1996). In addition, MC proteases have been suggested to 
degrade  endogenous  and  exogenous  toxic  peptides  and  to  enhance 
resistance to parasites (Knight et al., 2000) (Metz et al., 2006). Moreover, 
MCs produce lipid mediators, which modulate further MC mediator release 
and improve the innate host response by recruitment of proinflammatory 
cells (Metz & Maurer, 2007).  43 
 
In  response  to ectoparasites, gastrointestinal helminths and nematodes, 
MCs could be influenced and up-regulated by Th-2 responses (McDermott 
et  al.,  2003;  Lantz  et  al.,  1998)  (Woodbury  et  al.,  1984).  Interestingly, 
mMCP-1 has been shown to be important for a full intestinal host response 
during  Trichinella  spiralis  infection  (Knight  et  al.,  2000).  In  addition,  a 
possible involvement of MCs in effective responses toward many parasites 
such  as  Schistosomes,  Filaria,  Giardiasis  and  Toxoplasma  have  been 
demonstrated (Cutts & Wilson, 1997) (Li et al., 2004) (Ferreira et al., 2004). 
The use of MC-deficient WBB6F1-W/W
v mice established that MCs may 
have a protective role in Plasmodium spp. infection and that they control 
skin T cell-dependent host defense in Leishmania major infections (Furuta et 
al., 2006) (Maurer et al., 2006).   
Overall, the mechanisms by which MCs elicit these protective functions 
are diverse and dependent on the site, kinetics and pathogen involved. For 
example, in acute septic peritonitis, endothelin (ET)-1 is known to induce 
degranulation  of  MCs.  Conversely,  signals  through  TLRs do  not  induce 
MC  degranulation  but  rather  induce  the  secretion  of  newly  synthesized 
mediators  such as cytokines and chemokines, for example, IL-12, which 
may improve host survival during polymicrobial infections (Marshall, 2004) 
(Nakano et al., 2007). The possible contribution of MCs in the response to 
the protozoan parasite, Toxoplama gondii, has not been extensively studied. 
In  one  study,  the  leukotriene,  LTB4,  released  from  MCs  was  found  to 
damage the tachyzoites, suggesting an important role of eicosanoids in host 
defense (Henderson & Chi, 1998). Further, a significant influx of MCs into 
the site 1 h after i.p injection of the parasite was observed, suggesting that 
MCs may be involved in the acute phase of the infection. In addition, MC-
deficient mice displayed a defect in polymorphonuclear (PMN) leukocyte 
migration after i.p injection with T. gondii, which indicated MCs as a source 
of chemokines driving the recruitment of PMN cells (Del Rio et al., 2001) 
(Ferreira et al., 2004).  
In ovine, bovine and equine species, the protective role of MCs against 
parasites  has  not  been  so  extensively  studied.  However,  the  few  studies 
performed  support  the  experimental  evidence  in  the  mouse  model  and 
suggest  a  role  for  MCs  in  livestock  in  their  responses  to  parasitic 
infection.  Lambs  and  kids  challenged  with the  gastrointestinal  parasite, 
Teladorsagia  circumcincta,  displayed an  increased  number  of  MMCs  in  the 
tissues  (Macaldowie  et  al.,  2003).  Additionally,  alveolar  mastocytosis 
developed  in  the  lungs  of  lambs  with  the  naturally  acquired  nematode, 
Protostrongylus  rufescens  infections  (Mansfield  &  Gamble,  1995).  Further, 
extensive MC degranulation in cases of bovine respiratory syncytial virus-  44
associated paroxystic respiratory distress syndrome has been observed (Jolly 
et  al.,  2004).  Calves  infected  with  Pasteurella  heamolytica  displayed  a 
reduction in numbers of pulmonary MCs in the areas of acute inflammation 
by pneumonia (Ramirez-Romero et al., 2000). Lastly, equine MC and MC 
proteinases  have  been  implicated  in  the  response  to  infection  by  the 
intestinal nematode, Cyathostomin (du Toit et al., 2007). 45 
 
4  Present investigation  
4.1  Aims 
Since  the  development  of  the  SG-deficient  mouse  strain  (Abrink  et  al., 
2004), a number of studies have addressed the potential role and possible 
biological  function  of  SGPGs  in  different  hematopoietic  cell  types.  In 
particular, the functional role of SGPGs for the storage and activity of MC-
proteases has been studied intensively. However the possible roles during 
infection remain less well studied. In this thesis, the possible roles of MC, 
MC proteases and SGPGs in immune responses towards parasitic infection 
by T. gondii have been addressed, using the mouse as a model system. As the 
role of MCs during infections in large farm animals is rarely studied, this 
issue  has  been  addressed  in  an  experimental  lung  worm  infection  by 
analyzing the recruitment of tryptase-positive MCs, and tryptase expression 
in lung tissue. 
4.2  Serglycin-independent release of active mast cell proteases 
in response to Toxoplasma gondii infection  
SG-deficient  mice  display  defects  in  the  storage  of  neutrophil  elastase, 
granzyme  B,  platelet  factor  4,  β-thrombotubulin,  and  platelet  derived 
growth factor (Grujic et al., 2005) (Niemann et al., 2007) (Woulfe et al., 
2008). In addition, SG is the main secreted PG in peritoneal macrophages 
and TNF-α secretion by macrophages in response to LPS was found to be 
regulated  by  SG  (Zernichow  et  al.,  2006).  However,  the  most  dramatic 
effects  caused  by  the  targeted  deletion  of  SG  were  noted  in  MCs.  SG-
deficient  MCs  displayed  defects  in  the  morphology  of  their  secretory   46
granules and failed to retain MC-specific proteases, mMCP-4, -5, -6, and 
MC-CPA (Abrink et al., 2004) (Braga et al., 2007) (Ringvall et al., 2008).  
 In this study, we sought to reveal the possible contribution of SGPGs 
during  parasitic  infections,  using  T.  gondii  as  the  infectious  agent.  We 
injected the virulent RH strain into the peritoneum and followed the mice 
up to 8 days. Early effects of SG-deficiency were found, such as delayed 
neutrophil  recruitment  and  significant  reduction  in  the  recruitment  of 
CD117-positive cells (probably MCs) into the peritoneum. Moreover, the 
number  of  degranulated  MCs  was  found  to  be  significantly  higher  in 
infected WT compared to SG
-/- animals at 12 h and 24 h, which indicates 
the involvement and activation of MCs in response to parasitic infection. 
However, as these differences vanished by 48 h, possibly suggesting that 
other SG-independent mechanisms could take over by this time point, we 
focused our analysis on the early time points.  
The surprising restoration of the SG-dependent MC-specific proteases in 
the  peritoneum  of  infected  SG
-/-  mice  prompted  us  to  investigate  the 
possible mechanism, compensatory or not, behind this result. A sequential 
assessment of the enzymatic activities related to the MC-specific proteases 
showed that both SG
-/- and WT animals have increased activities, which in 
consistent with the reappearance of MC-proteases in Western blot analyses. 
 A possible explanation for the restored activation of MC-proteases in 
the SG-deficient mice in vivo, is that other PGs may compensate. Another 
possibility  is  that  MC-proteases  could  act  independently  of  SGPGs once 
released from the MC. To this end, we isolated and analyzed GAGs from 
peritoneum  of  infected  WT  and  SG
-/-  mice  at  48  h  post-infection. 
Interestingly, a massive SG-independent release of hyaluronan and CS was 
noted, but only minimal levels of heparin/HS were found in the lavage 
fluid. A high salt extraction of heparin/HS did not increase the recovered 
amounts,  suggesting  that  most  of  the  heparin/HS  is  cell-associated.  As 
others  have  reported  that  heparin  is  the  main  GAG  involved  in  MC-
protease activation and possibly acts in a complex with proteases (Hallgren 
et  al.,  2001)  (Henningsson  et  al.,  2002),  we  next  analyzed  whether  the 
heparin/HS pool in the peritoneum was confined to the cellular pool or 
reabsorbed by surrounding tissues after secretion. In support of a cellular 
association of heparin, analysis of the GAG-content in the peritoneal cell 
pool revealed heparin/HS in both challenged and naïve WT mice, although 
the amount of HS in the SG
-/- mice was less by a factor of 10 and was less 
sulfated. 
Our results suggest that MC-specific proteases can be functionally active 
during infection in vivo independently of SGPGs. GAG analysis indicates 47 
 
that  SG  is  the  major  heparin/HS-containing  PG  in  the  body  and  that 
heparin/HS  is  dispensable  for  secretion  and  activation  of  MC-specific 
proteases.  In  conclusion,  our  results  indicate  that  other  sulfated  CS/HS 
GAG  chains  induced  during  infection  may  provide  a  compensatory 
mechanism or that SGPGs are dispensable for the function of MC specific 
proteases in vivo when infected with Toxoplasma gondii. 
4.3  Serglycin proteoglycans contribute to mast cell cytokine 
secretion in vitro, and to early neutrophil recruitment and 
cytokine secretion in vivo, in response to Toxoplasma gondii 
We next conducted a study to evaluate the role of SG in vivo and in vitro 
after Toxoplasma gondii infection by measuring the cytokine profiles, parasite 
burden and other changes in the animals and in MC cultures. In line with 
study I, SG
-/- mice were found to recruit similar total leukocyte numbers 
and  to  have  similar  weight  losses  to  WT  mice,  due  to  the  infection. 
However,  SG
-/-  mice  had  significantly  delayed  neutrophil  recruitment, 
which may be attributed to a lack of certain MC proteases, such as mMCP-
6, previously shown to play a role in the recruitment of neutrophils (Huang 
et  al.,  1998).  In  addition,  the  delay  in  production  or  secretion  of  the 
cytokines  IL-6,  IL-12,  TNF-α  and  IFN-γ,  possibly  contributes  to  the 
observed  delay  in  neutrophil  recruitment.  In  vitro  analysis  of  cytokine 
secretion from STag-stimulated PCMCs indicated a significant role for SG 
in the production of these cytokines. Interestingly, MCP-1 levels in PCMC 
cultures  was  significantly  up-regulated in the SG
-/- PCMCs compared to 
WT PCMCs. However, as judged by qPCR, the expression levels of these 
cytokines were similar in SG
-/- and SG
+/+ both in vivo and in vitro.  
The T. gondii infection caused a systematic decrease of these cytokines in 
the serum of SG
-/- mice. Histopathological examination of the spleens from 
infected  animals  revealed  striking  differences  at  48  h  and  5  days  post-
infection.  The  periarteriol  lymphoid  sheath  (PALS)  in  infected  mice 
exhibited clear areas populated with cells having poorly demarcated borders, 
and with features corresponding to dendritic cells. In SG
-/-, these areas were 
more diffuse and infiltrated with polymorphonuclear cells. The parasite load 
inside the peritoneal cells at 48 h and numbers of free parasites in peritoneal 
exudates at 24 h were significantly higher in SG
-/- compared to WT animals. 
Our  results  indicate  that  SGPG  may  play  a  regulatory  role  in  the 
secretion of proinflammatory cytokines and host immune responses toward 
infection in general, processes which may depend on SG-dependent MC-
mediators.   48
4.4  Age-related enlargement of lymphoid tissue and altered 
leukocyte composition in serglycin-deficient mice 
Serglycin is the dominant PG in MCs, macrophages, neutrophils, CTLs and 
platelets, where it regulates the storage, secretion and activity of secretory 
granule constituents. The SG-deficient mouse strain appears normal, with 
no  gross  abnormality,  normal  lifespan  and  reproduction  is  not  affected 
(Abrink et al., 2004). However, and surprisingly, aging SG-deficient mice 
were found to develop spontaneous enlargements in lymphoid organs. In 
particular  the  spleen,  Peyer’s  patches  (PP),  and  bronchus-associated 
lymphoid tissue (BALT) were enlarged. We speculated that SG-deficient 
mice may be more susceptible to spontaneous infections and so attempted 
to clarify the observed phenomena. Careful systematic analysis showed that 
the  incidence  of  spleen  enlargement  was  ~37%  versus  ~7%,  and  PP 
enlargement  was  ~95%  versus  ~20%  when  SG-deficient  animals  were 
compared  with  WT  animals.  Further  analysis  of  SG
-/-  spleens  by 
histomorphology showed increased cellularity in the white pulp areas with 
less defined demarcation zones. Analyses using flow cytometry showed a 
significant increase in the percentage of CD45RC expressing cells, a surface 
molecule  normally  expressed  mainly  by  mature,  naïve  lymphocytes. 
Morphological  examination  of  SG
-/-  PP  also  showed  increased  leukocyte 
infiltration, whereas no major difference in the cellular profile could be seen 
when cells from SG and WT animals were analyzed by flow cytometry. 
Together,  this  suggests  that  the  enlargements  develop  from  an  influx  of 
multiple leukocytes rather than one specific cell type. Next, we investigated 
the profiles of the peritoneal cell population in young and old mice, and 
found  that  the  macrophage  proportion  in  aging  SG
-/-  mice  decreased 
significantly when compared with WT mice. Furthermore, although similar 
numbers of MCs were present in SG
-/- and WT animals, the level of c-kit 
(CD117)  surface  expression  was  significantly  lower  in  aging  SG
-/-  mice. 
Interestingly,  we  did  not  find  any  proof  of  ongoing  infections,  as  the 
proinflammatory cytokine levels in BALF and serum were similar in SG
-/- 
and WT animals.  This suggested that SG-deficiency spontaneously leads to 
the observed phenotype in aging mice.     
Finally, we investigated whether SG-deficiency influenced the general 
immune  responsiveness  on  challenge  with  LPS,  a  bacterial  cell  wall 
component. In aging SG
-/- mice, intranasal provocation with LPS showed a 
significant  increase  in  the  total  cell  number  and  a  trend  toward  higher 
counts of neutrophils and lymphocytes in BALF, when compared with WT 
mice. Lung tissues displayed more lesions in peribronchial and perivascular 49 
 
tissue,  an  effect  possibly  due  to  increased  leukocyte  infiltration,  and 
suggesting a regulatory role for SG in the inflammatory response.  
These results confirm that SG is an important component of the immune 
system  and  for  the  homeostasis  of  granule  components.  Moreover,  the 
diverse changes associated with a lack of SG may be attributed to a role for 
SG  in  the  regulation  of  cytokines  necessary  for  some  differentiation 
processes.  
4.5  Tryptase-positive mast cells accumulate in bovine lung 
tissues during Dictyocaulus viviparus infection 
D. viviparus induces a host immune response with a potential role for γ/δ 
TCR-expressing cells in the immune response of the airways, as previously 
shown during experimental infection (Hagberg et al., 2005). In addition, 
the levels of IgE correlated positively with the infection, which implied that 
D. viviparus induces a Th2 profile (Kooyman et al., 2002). However, as few 
studies have been performed to address MC responses during D. viviparus 
infection,  we  investigated  the  airway  MC  responses  during  experimental 
infection.  To  this  end,  we  analyzed  lung  tissues,  BAL-fluid  and  blood 
samples  from  infected  calves,  collected  at  different  time  points  during 
disease  progression,  and  noted  a  significant  increase  in  plasma  histamine 
levels on days 3 and 5, and a significant increase of tryptase-positive MCs in 
the airways on day 14.  
The  sequential  movement  of  D.  viviparus  from  the  intestine  through 
lymph nodes to lung tissue in experimentally infected calves causes different 
host immune responses. The increased histamine levels probably reflect the 
early response by the MCs in the intestinal mucosa and lymph nodes, rather 
than those located in the lung. Toluidine blue and immunohistochemistry 
staining of the lung tissue, with significantly increased MC numbers on day 
14, suggests that a major MC recruitment to the infection site only occurs 
when  the  parasite  has  reach  its  preferred  tissue  site.  The  increased  MC 
numbers were then further evaluated. Expression of tryptase was confirmed 
by  qPCR,  and  was  shown  to  consistently  increase  during  the  course  of 
infection. As expected, counting of BAL cells from infected animals on day 
14  indicated  a  massive  infiltration  of  leukocytes,  but  interestingly,  MCs 
were also found in significant numbers among the BAL cells, as confirmed 
by  qPCR  for  the  tryptase  gene.  Previous  studies  (Welle  et  al.,  1995) 
(Kuther  et  al.,  1998)  indicated  that  the  use  of  an  anti-human  tryptase 
antibody  enabled  the  detection  of  bovine  tryptase.  We  used  both  a   50
monoclonal and a polyclonal anti-human tryptase antibody to detect bovine 
tryptase in Western blots, but were unable to obtain reliable data.  
Together, our results show that tryptase-positive MCs are recruited to 
infection sites in response to D. viviparus, where MCs are likely to play a 
role in the pathogenesis of the disease.  51 
 
5  Concluding remarks and future perspectives  
MCs have been regarded as the “bad guy” in many pathological conditions, 
particularly due to their devastating role in allergies. On the other hand, 
recent studies using naturally occurring MC- deficient and/or genetically 
targeted  mice  have  shown  that  MCs  have  beneficial  and  protective 
functions  both  in  normal  physiology  and  during  severe  pathological 
conditions.  With  the  development  of  SG-deficient  mice,  we  and  others 
were able for the first time to address the potential role of SGPGs during in 
vivo infections. However, many questions about exact mechanistic roles still 
remain to be answered.  
In this thesis, we addressed the issue of how SGPG-deficiency may affect 
the  immune  response  towards  the  protozoan  parasite,  T.  gondii.  We 
observed  unexpected  consequences  in  the  absence  of  SG;  the  most 
interesting was the restoration of SG-dependent MC proteases in infected 
animals.  We  have  proposed  some  possible  solutions  to  this  mystery,  but 
further  investigations  are  required  to  reveal  more  information  about  the 
mechanisms  at  work.  Our  future  work  will  be  aimed  at  resolving  the 
mechanism  that  compensates  for  the  absence  of  SG  after  MC-specific 
proteases are released. Intracellular immunostaining may be used to further 
study  different  cytokines,  particularly  MCP-1,  which  showed  a  striking 
difference  in  secretion  when  SG
-/-  and  WT  PCMCs  were  compared  in 
tissue  culture.  Furthermore,  it  will  be  interesting  to  continue  work  that 
reveals more about the mechanism on how a lack of SG results in an early 
transit  defect  in  recruitment  of  neutrophils  and  then  try  to  identify  the 
precise role of each of the SG dependent/independent MC-mediators. A 
first approach will include the use of gene/cDNA microarrays, which may 
indicate the genes that are most up- and down-regulated in our in vivo and 
in vitro infection models. Another way to address this apparent delay in 
neutrophil  recruitment  is  with  the  use  of  mouse  strains  selectively  and   52
genetically  targeted  for  MC-proteases.  We  have  access  to  mMCP-4 
(chymase), mMCP-6 (tryptase), and MC-CPA knockout strains as well as 
the MC deficient Wsash mouse strain, which can be functionally restored 
with MCs, including those with specific deletions, through intraperitoneal 
adoptive transfer.  
As peritoneal injection is far from the natural route of infection, we also 
plan  to  study  the  chronic  form  of  the  disease  by  oral  administration  of 
infection, where we can conduct a study on the involvement of MMCs in 
addition to CTMCs through tissue cyst formation.  
Peritoneal-derived  MCs  (PCMCs)  produce  more  mature  MCs  than 
cultures of BMMCs. This is why they are likely to be useful for detailed in 
vitro studies of the interaction between MCs and pathogens in studies on 
parasite recognition receptors expressed on MCs.  
An  important  goal  will  be  to  study  the  diffuse  functions  of  MCs  in 
domestic  animals,  with  the  emphasis  on  parasitic  diseases,  by 
characterization of the cells and the development of new methods to enable 
the optimal performance of these studies.  
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 ﻮﻟو در ﻊﻴﻄﺘ ﺳٔ  نٔ  ﻞﻣٓ  ،ﲂّ ﺣو ﲂﺘﻴﺤﻀﺗ ﲆ  ﰼﺮﻜﺸﻟ ﺔ ﻓﲀﻟا تﲈﳫﻟا ﺪ ٔ  ﻻ ،ي اوو ﰐ او ﱃٕا
ﻧذٕ  ﲂﻠﻀﻓ ﻦﻣ ًﺎﻄﻴ ﺴ  اًءﺰﺟ ﱃﺎﻌﺗ ﻪ .  
  ﻟﺎﻐﻟا ﱵﺟوز ﱃٕا  يراﻮﺸﻣ تﺎﻈﳊ ﻊﻴﲨ ﱄ ﻚﺘﻛرﺎﺸﻣو ،ﻚ ﻮﺿوو ،ﻚﺒُﳊ ،  ﻞﻳﺰﳉا ﺮﻜﺸﻟا ،ﺔﻴ
 ﻲﻘ ﻘﳊا ﲎﻌﳌاو ﺮﻫﻮﳉا ،ن رو ىؤر ،ﲔﺗﺮﻫز ﻦﺴﺣٔ  ﺎ ﻣٔ و ،ﺔﻌﺋار ﺔ وز ﺖﻨﻛ ﺪﻘﻟ ﻞﻌﻔﻟ  ؛ﻞﻳﻮﻄﻟا
ﺎﻨﺗﺎﻴﳊ .  
 ةﺪﻧﺎﺴﻤﻠ  ﺐﻴﻃﺮﻟا ﻲﺤ ﻓو ﺔﻌﲨ  ﺋﺎ  ﱃٕاو ،ﺔﻣﱰﶈا ﻢﲥﻼﺋﺎ و ﰐاﻮﺧٔ و ﰐﻮﺧٕﻻ ﻞﻳﺰﳉا ﺮﻜﺸﻟا
ﺔﺒﻴﻄﻟا ﺮﻋﺎﺸﻤﻠ و .  
 يﺮﻄﻴﺒﻟا ﺐﻄﻟا ﺔﻴﳇ ﰲ ءﻼﻣﺰﻟا ﰻ ﱃٕاو ،ﺎ  ﻴﻟ ﰲ ﰄﻼﻣزو ﰄﺎﻗﺪﺻٔ  ﻊﻴﶺ ﺮ ﺎﺷو ﱳﳑ  ٔ  ،ًاﲑ ٔ 
ﰌﺎﻔﻟا ﺔﻌﻣﺎﲜ     ﺲﻠﺑاﺮﻃ .  
 
 
 
 